Donghyun Lim

Title: The Innovations of Donghyun Lim

Introduction

Donghyun Lim is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of genetic engineering, particularly in the area of nucleic acid modifiers. His work focuses on the development of novel technologies that enable precise modifications to DNA.

Latest Patents

Donghyun Lim holds 1 patent related to nucleic acid modifiers. This patent encompasses site-specific delivery mechanisms for nucleic acid modifiers, including innovative DNA-binding proteins and effectors. The inventions also introduce a synthetic all-in-one genome editor (SAGE) system, which features designer DNA sequence readers and small molecules that facilitate double-strand breaks, enhance cellular permeability, inhibit non-homologous end joining (NHEJ), and activate homology-directed repair (HDR). These advancements provide new methods for delivering and utilizing these systems in genetic research and therapy.

Career Highlights

Throughout his career, Donghyun Lim has worked with prestigious organizations, including the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to collaborate with leading scientists and contribute to groundbreaking research in genomics and molecular biology.

Collaborations

Some of his notable coworkers include Kurt Cox and Soumyashree Ashok Gangopadhyay. Their collaborative efforts have further advanced the research and development of innovative genetic technologies.

Conclusion

Donghyun Lim's contributions to the field of genetic engineering through his patent on nucleic acid modifiers highlight his role as a leading inventor in this area. His work continues to influence advancements in genome editing and molecular biology.